Filing Details

Accession Number:
0001415889-24-026758
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-13 19:43:02
Reporting Period:
2024-11-11
Accepted Time:
2024-11-13 19:43:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1761612 Bicycle Therapeutics Plc BCYC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1983944 Alvin Travis Thompson C/O Bicycle Therapeutics Plc
Blocks A &Amp; B, Portway Building
Cambridge X0 CB21 6GS
Chief Accounting Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2024-11-11 1,312 $1.87 24,234 No 4 M Direct
Ordinary Shares Disposition 2024-11-11 1,312 $25.05 22,922 No 4 S Direct
Ordinary Shares Acquisiton 2024-11-11 154 $8.21 23,076 No 4 M Direct
Ordinary Shares Disposition 2024-11-11 154 $25.01 22,922 No 4 S Direct
Ordinary Shares Acquisiton 2024-11-11 1,109 $9.82 24,031 No 4 M Direct
Ordinary Shares Disposition 2024-11-11 1,109 $25.05 22,922 No 4 S Direct
Ordinary Shares Disposition 2024-11-11 3,241 $25.21 19,681 No 4 S Direct
Ordinary Shares Disposition 2024-11-11 209 $24.77 19,472 No 4 S Direct
Ordinary Shares Disposition 2024-11-11 231 $24.82 19,241 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Employee Stock Option (right to buy) Disposition 2024-11-11 1,312 $0.00 1,312 $1.87
Ordinary Shares Employee Stock Option (right to buy) Disposition 2024-11-11 154 $0.00 154 $8.21
Ordinary Shares Employee Stock Option (right to buy) Disposition 2024-11-11 1,109 $0.00 1,109 $9.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,617 2028-09-17 No 4 M Direct
302 2029-04-24 No 4 M Direct
12,954 2029-04-24 No 4 M Direct
Footnotes
  1. This transaction occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2024.
  2. This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.28836 to GBP 1.00 as of November 11, 2024.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4), (5) and (6).
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.08 inclusive.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.73 to $24.81 inclusive.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.82 to $24.825 inclusive.
  7. This option is fully vested and exercisable.